Techniques and Devices for Catheter-Directed Therapy in Pulmonary Embolism

Tech Vasc Interv Radiol. 2017 Sep;20(3):185-192. doi: 10.1053/j.tvir.2017.07.008. Epub 2017 Jul 5.

Abstract

The clinical presentation of a patient with acute pulmonary embolism (PE) can be classified into 3 categories: low-risk, submassive (presence of right heart strain), and massive (hemodynamic compromise). Massive PE is associated with high morbidity or mortality and typically treated with systemic intravenous thrombolysis. Over the last 2 decades, however, catheter-directed techniques have become an increasingly popular treatment modality for patients with a contraindication to systemic thrombolysis or without clinical improvement after systemic thrombolysis. Furthermore, endovascular treatment for patients with submassive PE has been of great interest due to the significantly increased mortality associated with right heart strain, and prospective clinical trials have demonstrated catheter-directed thrombolysis to decrease right heart strain earlier than systemic anticoagulation alone. This article describes available devices and endovascular techniques used to treat patients with massive and submassive acute PE.

Keywords: Pulmonary embolism; catheter-directed therapy; thrombectomy; thrombolysis.

Publication types

  • Review

MeSH terms

  • Adult
  • Computed Tomography Angiography
  • Endovascular Procedures / adverse effects
  • Endovascular Procedures / instrumentation*
  • Endovascular Procedures / mortality
  • Equipment Design
  • Female
  • Fibrinolytic Agents / administration & dosage*
  • Fibrinolytic Agents / adverse effects
  • Hemodynamics
  • Humans
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Pulmonary Embolism / diagnostic imaging
  • Pulmonary Embolism / mortality
  • Pulmonary Embolism / physiopathology
  • Pulmonary Embolism / therapy*
  • Risk Assessment
  • Risk Factors
  • Thrombectomy / adverse effects
  • Thrombectomy / instrumentation*
  • Thrombectomy / mortality
  • Thrombolytic Therapy / adverse effects
  • Thrombolytic Therapy / instrumentation*
  • Thrombolytic Therapy / mortality
  • Treatment Outcome
  • Vascular Access Devices*

Substances

  • Fibrinolytic Agents